Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

Presentation TCT 2024

TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype

Presenter: TsungYing Tsai

October 30, 2024

Presentation TCT 2024

TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome

Presenter: Francesca Maria Di Muro

October 29, 2024

Presentation TCT 2024

I Measured Lipoprotein (a): What was I Thinking, and Now What Do I Do?

Presenter: Dipti Itchhaporia

October 29, 2024

Presentation TCT 2024

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

Presenter: Woo Jin Ahn

October 29, 2024

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Todd Neale

October 15, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

News Conference News ACC 2024

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

Yael L. Maxwell

April 06, 2024

News Daily News

Niacin, When Broken Down by the Body, Can Spur Inflammation

Caitlin E. Cox

February 22, 2024

News Daily News

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

Todd Neale

February 14, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

Presentation Complex Coronary Cases 2023

Lipoprotein(a): The New Kid on the Block

Presenter: Pam R. Taub

June 15, 2023

Advertisement

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype

TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome

I Measured Lipoprotein (a): What was I Thinking, and Now What Do I Do?

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

Niacin, When Broken Down by the Body, Can Spur Inflammation

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

February 2024 Dispatch for the CV Team

Lipoprotein(a): The New Kid on the Block

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content